Clinical Trial Update: Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Ongoing Phase 3 trial evaluating netakimab in children with moderate to severe plaque psoriasis; status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Netakimab (netakimab)

Snippet

Sponsor: Biocad | Conditions: Plaque Psoriasis | Phase 3 | Status: ACTIVE_NOT_RECRUITING